Labcorp Holdings (LH) Receivables (2009 - 2026)

Labcorp Holdings has disclosed Receivables across 18 years of filings, most recently posting $2.5 billion for Q1 2026.

• Receivables for Q1 2026 came in at $2.5 billion, up 7.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 billion (up 7.74% YoY), and the FY2025 annual result was $2.3 billion, up 7.81% from the prior year.
• Receivables came in at $2.5 billion for Q1 2026 at Labcorp Holdings, up from $2.3 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $3.0 billion in Q1 2023 to a low of $1.3 billion in Q4 2022.
• The 5-year median for Receivables is $2.3 billion (2025), against an average of $2.3 billion.
• Peak annual rise in Receivables reached 66.74% in 2023, while the deepest fall reached 32.89% in 2023.
• Labcorp Holdings' Receivables stood at $1.3 billion in 2022, then jumped by 66.74% to $2.1 billion in 2023, then retreated by 0.08% to $2.1 billion in 2024, then increased by 7.81% to $2.3 billion in 2025, then grew by 8.4% to $2.5 billion in 2026.
• The last three Receivables figures came in at $2.5 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.3 billion (Q3 2025), per Business Quant data.